ERIC MEAUX: Open Payments
NPI 1467959718 · FRANKLIN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 24 payments from 10 companies in 2025. Trend: 2023 $516 · 2024 $424 · 2025 $546
Food & beverage: $371Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Verona Pharma, Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Novo Nordisk Inc | 2 | $29 |
| Lundbeck LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: PROLIA, JARDIANCE, Kerendia, Ohtuvayre, VERQUVO, Ozempic, REXULTI, EVENITY.
Industry payments across LA — which companies pay providers there.
